How much will this cost?” he asks. It’s the question at the heart
of any business transaction: Is this new car, this plane ticket, this
iPad worth the asking price?
But the man sitting before me is not a customer in an automobile
showroom or an electronics store. He is my patient in the emergency
department, and he is weighing whether to undergo the chest CT scan I
have just recommended.
“I’m uninsured,” he says. “I lost my health coverage when I got laid
off from my job three years ago. This is all coming out of my pocket.”
An
ex-smoker in his late 40s, he has been coughing up increasing amounts
of bloody sputum over the past month. What began as occasional, tiny red
flecks has progressed to thick crimson streaks he can no longer ignore.
“I can only give you an estimate,” I say, “but I’m guessing a chest
CT scan plus the radiologist’s fee will run in the neighborhood of
$2,000.”
“I was afraid you’d say something like that,” he says. “I figured CT
scans don’t come cheap.” He sighs quietly. “I’m raising my 8-year-old
daughter on a pretty lean budget.” He looks thin in his hospital gown
and a shade pale, a few days of graying stubble on his chin.
“But I’ve been worried about this for too long,” he says. “I know I need to have it.”
An hour later, I am seated at my computer scrolling through digital
CT images while the radiologist on the phone describes the findings.
“In the hilum of the left lung there is a 4.5 centimeter lesion very
likely to represent malignancy,” she says. My gaze falls on the
irregularly shaped white mass, its tiny tentacles invading the delicate
latticework of the surrounding lung tissue.
“Unfortunately, it gets worse,” the radiologist says. “There are also
multiple scattered smaller lesions throughout both lungs, highly
suspicious for metastases.”
There was a time during medical school and residency when I regarded
abnormal clinical and radiographic findings with intrigue. I remember
the excitement of hearing my first heart murmur. Of palpating a thyroid
nodule. Of visualizing an ovarian mass on pelvic ultrasound.
But after years of clinical practice and countless patient
encounters, I now find it difficult to view abnormal findings separately
from the human lives they affect. I see an elderly woman’s hip X-ray,
knowing that the fracture line coursing through the femoral neck likely
spells the end of her days of independent living. A peculiar bright
patch lighting up in the brain’s left hemisphere on an MRI scan
signifies that a man will no longer be able to grasp a pen or a coffee
mug in his right hand, will never again be able to speak a meaningful
word to his family.
I hang up the phone, my eyes lingering on the CT images, the sinister
white lung mass and its small-but-ominous satellites. And I am aware of
their significance—that a middle-aged man will not live to see his
daughter’s wedding.
I return to the patient’s room and sit down on the bedside stool.
Before I speak, I feel his gaze upon me, anxiously searching my face for
any subtle indication of the words to come.
“I’m sorry to have to give you this news,” I say, “but your CT scan
shows findings concerning for lung cancer. It’s possibly spread to both
lungs.”
He stares ahead, unblinking, his facial pallor seemingly more apparent. After a few moments, he speaks.
“On some level, I was expecting something really bad like this,” he
says. “But, of course, you always hope that everything will turn out
fine.”
My mouth, having grown dry, lacks the appropriate words to console
him in this moment of utter sorrow. So I put a hand on his arm.
“I’ll talk to our on-call oncologist,” I tell him. “We’ll figure out a plan for you.”
He waits patiently until I return to his room once more, armed with an action plan. “The oncologist is going to admit you to the hospital and start the
workup,” I explain. “He’ll order a PET scan to see if there’s been
spread to other parts of the body. Then they’ll do a biopsy of that main
lesion in your lung to determine the best treatment options—whether it
be radiation, chemotherapy or some combination of the two.”
A long period of silence follows, time for my patient to process the
information I have conveyed. I anticipate forthcoming questions.
“I suspected that you’d want to do all those things,” he says,
finally. “But I’ve already been thinking this through, and I’ve decided
that I’m going to have to pass on your recommendations.”
It is not a reply I was expecting. “Why is that?” I ask.
“As I said before, I’ve got no health insurance,” he says. “But
there’s one thing I do have—my house. And it’s fully paid for. I guess
I’m not willing to mortgage it—and ultimately lose it—to pay off endless
medical bills. My house is the only thing…” His voice trails off. After a pause, he continues. “My house is the only thing I’ll have to leave my daughter when I’m gone.”
Tears have gathered in the corners of his eyes. I offer him a box of tissues, and he takes one.
We sit together in a room in a modern emergency department in a rich
country, a land where highly trained specialists confidently wield the
newest technologies and expensive pharmaceuticals. But these treasures
are not accessible to all, for ours is also a land where private health
insurance is bought and sold as a commodity. Ours is a system known to
shake down sick people for money they don’t have. Ours is the only
wealthy democracy that fails to guarantee health coverage to all of its
citizens.
Just as it is failing now.
He looks down at his watch. “Thanks for all you’ve done. I really
appreciate it. But I’ve gotta leave now,” he says. “I have to go pick
her up from school.”
As I watch him reach behind his neck to untie his hospital gown, I
can’t help but feel that we owe him so much more. I can’t help but feel
that we—health care providers, hospital administrators, insurance
company executives, politicians, all those who strenuously fight the
changes that our system desperately needs—we all have failed him.
I can’t help but feel that we are better than this.
This article first appeared in the July 2012 issue of Minnesota Medicine.